Safety and Pharmacokinetic Study of NPT 2042 Soft-gelatin Capsules Administered Orally to Healthy Adult Subjects
Clinical trial NCT05503511 · COMPLETED
Trial details
- NCT number
- NCT05503511
- Sponsor
- NeuroPro Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-20
- Primary completion
- 2023-03-17
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.